financetom
Business
financetom
/
Business
/
Restaurant Brands International Insider Sold Shares Worth $18,507,758, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Restaurant Brands International Insider Sold Shares Worth $18,507,758, According to a Recent SEC Filing
May 9, 2024 12:47 AM

03:17 AM EDT, 05/09/2024 (MT Newswires) -- Joshua Kobza, Chief Executive Officer, on May 06, 2024, sold 246,196 shares in Restaurant Brands International (QSR) for $18,507,758. Following the Form 4 filing with the SEC, Kobza has control over a total of 675,599 shares of the company, with 675,599 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1618756/000161875624000087/xslF345X03/wk-form4_1715212368.xml

Price: 74.87, Change: +1.49, Percent Change: +2.03

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Workday Fiscal Q1 Earnings, Revenue Rise; FY 2025 Subscription-Revenue Guidance Cut; Shares Sink Premarket
Update: Workday Fiscal Q1 Earnings, Revenue Rise; FY 2025 Subscription-Revenue Guidance Cut; Shares Sink Premarket
May 24, 2024
06:20 AM EDT, 05/24/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Workday (WDAY) shares were down 12% in premarket activity on Friday after the company cut its fiscal 2025 subscription-revenue guidance, taking the shine out of its Q1 earnings and revenue beat. The company reported fiscal Q1 non-GAAP net income late Thursday...
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
May 24, 2024
May 24 (Reuters) - Novo Nordisk's Ozempic slowed the worsening of kidney dysfunction in patients with type 2 diabetes and lowered the risk of kidney failure, heart problems, stroke and death, according to detailed results from a late-stage trial presented on Friday. The company in March reported that the diabetes drug known chemically as semaglutide cut the combined risk of...
Fairfax Asia Chairman/CEO Athappan Passes Away
Fairfax Asia Chairman/CEO Athappan Passes Away
May 24, 2024
06:31 AM EDT, 05/24/2024 (MT Newswires) -- Fairfax Financial ( FRFHF ) overnight Thursday said Fairfax Asia Chairman and CEO Ramaswamy Athappan has passed away. The company didn't mention the cause of death or Athappan's age. He played a major role in developing Fairfax's insurance operations in Southeast Asia, the company said. Mr. Athappan was an exceptional leader with an...
Workday Cuts Fiscal 2025 Subscription Revenue Guidance Despite First-Quarter Beat
Workday Cuts Fiscal 2025 Subscription Revenue Guidance Despite First-Quarter Beat
May 24, 2024
06:30 AM EDT, 05/24/2024 (MT Newswires) -- Workday (WDAY) shares tanked early Friday as the cloud human resources company lowered its full-year subscription sales outlook amid slowing headcount growth, despite recording better-than-expected fiscal first-quarter results. Subscription revenue is now set to come in between $7.7 billion and $7.73 billion for fiscal 2025, representing annual gains of about 17%, the company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved